Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.67 AUD | -2.52% | +2.59% | +45.54% |
Apr. 30 | Bell Potter Downgrades Telix Pharmaceuticals to Hold from Buy, Price Target is AU$14.50 | MT |
Apr. 18 | Jarden Adjusts Telix Pharmaceuticals Price Target to AU$13.52 from AU$13.27, Keeps at Buy | MT |
Sales 2024 * | 741M 480M | Sales 2025 * | 937M 607M | Capitalization | 4.97B 3.22B |
---|---|---|---|---|---|
Net income 2024 * | 48M 31.11M | Net income 2025 * | 103M 66.75M | EV / Sales 2024 * | 6.54 x |
Net cash position 2024 * | 128M 82.81M | Net cash position 2025 * | 195M 126M | EV / Sales 2025 * | 5.1 x |
P/E ratio 2024 * |
99.7
x | P/E ratio 2025 * |
47.8
x | Employees | 234 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.41% |
Latest transcript on Telix Pharmaceuticals Limited
1 day | -2.52% | ||
1 week | +2.59% | ||
Current month | +13.81% | ||
1 month | +16.61% | ||
3 months | +26.03% | ||
6 months | +66.33% | ||
Current year | +45.54% |
Managers | Title | Age | Since |
---|---|---|---|
Andreas Kluge
FOU | Founder | - | 15-10-31 |
Founder | - | 15-10-31 | |
Darren Smith
DFI | Director of Finance/CFO | 58 | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Harry McCann
CHM | Chairman | 83 | 17-09-16 |
Founder | - | 15-10-31 | |
Mark Nelson
BRD | Director/Board Member | - | 17-09-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.39% | 16 M€ | -5.68% | ||
0.04% | 773 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 14.67 | -2.52% | 1 349 905 |
24-04-30 | 15.05 | -2.97% | 1,355,980 |
24-04-29 | 15.51 | +4.02% | 1,278,885 |
24-04-26 | 14.91 | +0.20% | 1,700,410 |
24-04-24 | 14.88 | +4.06% | 1,735,593 |
Delayed Quote Australian S.E., May 01, 2024 at 02:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.54% | 3.23B | |
+0.17% | 42.19B | |
+10.92% | 42.24B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.23% | 24.63B | |
-24.79% | 18.2B | |
+26.69% | 12.01B | |
-3.13% | 11.76B | |
+6.57% | 10.4B |
- Stock Market
- Equities
- TLX Stock